EP2945633
USE OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
13.1.2014EP published:
30.6.2021EP application number:
14703426.8
EPO information:
European Patent Register
Max expiry date:
12.1.2034
Title:
USE OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS
Timeline
Today
13.1.2014EP application
30.6.2021EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
FENDT, MarkusAddress:
CH-4002 Basel, CH
Name:
FEUERBACH, DominikAddress:
CH-4002 Basel, CH
Name:
FINNEMA, Sjoerd JohannesAddress:
S-171 76 Stockholm, SE
Name:
HALLDIN, ChristerAddress:
S-171 76 Stockholm, SE
Name:
JOHNS, DonaldAddress:
Cambridge, Massachusetts 02139, US
Name:
LOPEZ-LOPEZ, CristinaAddress:
CH-4002 Basel, CH
Name:
MCALLISTER, Kevin HallAddress:
CH-4002 Basel, CH
Name:
SOVAGO, JuditAddress:
CH-4002 Basel, CH
Name:
WEISS, MarkusAddress:
CH-4002 Basel, CH
Priority
Number:
201361752772 PDate:
15.1.2013Country:
US
Classification
Categories:
A61K 31/501, A61K 31/506, A61K 31/55, A61P 25/26, A61K 31/4545, A61P 43/00